Orphan Drug Act

Results: 190



#Item
17121st Century Cures: Incorporating the Patient Perspective U.S. House of Representative Energy and Commerce Committee Subcommittee on Health July 11, 2014 Good morning, Mr. Chairman and Members of the Committee. I am Dr.

21st Century Cures: Incorporating the Patient Perspective U.S. House of Representative Energy and Commerce Committee Subcommittee on Health July 11, 2014 Good morning, Mr. Chairman and Members of the Committee. I am Dr.

Add to Reading List

Source URL: docs.house.gov

Language: English - Date: 2014-07-10 09:42:43
172Microsoft Word - FINAL Call for Tender CAVOD 19Mar10.doc

Microsoft Word - FINAL Call for Tender CAVOD 19Mar10.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-04-23 10:40:36
173Delphi Survey on Neglected and Orphan Diseases Project Summary Research questions: 1) Which incentives are effective in stimulating research and development on neglected and orphan diseases?

Delphi Survey on Neglected and Orphan Diseases Project Summary Research questions: 1) Which incentives are effective in stimulating research and development on neglected and orphan diseases?

Add to Reading List

Source URL: www.fabrycanada.com

Language: English - Date: 2012-02-26 16:47:18
174

PDF Document

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-04-26 10:07:40
175Inventory of Community and national incentive measures to aid the research, marketing, development and availability of orphan medicinal products Background Regulation (EC) No[removed]of the European Parliament and of t

Inventory of Community and national incentive measures to aid the research, marketing, development and availability of orphan medicinal products Background Regulation (EC) No[removed]of the European Parliament and of t

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:12:02
176Microsoft Word - updated inventory august 2002.doc

Microsoft Word - updated inventory august 2002.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:11:39
177Microsoft Word - Final final report part 1_publ.doc

Microsoft Word - Final final report part 1_publ.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:12:01
178Microsoft Word - Final final report part 2_publ.doc

Microsoft Word - Final final report part 2_publ.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:12:01
179United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION,

United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION,

Add to Reading List

Source URL: www.courthousenews.com

Language: English - Date: 2014-06-10 11:20:05
180Combating Rare Diseases in the 21st Century The Orphan Drug Act What is a Rare Disease?

Combating Rare Diseases in the 21st Century The Orphan Drug Act What is a Rare Disease?

Add to Reading List

Source URL: www.chi.org

Language: English - Date: 2014-02-27 15:16:35